计算机断层扫描衍生的定量影像生物标志物可预测系统性硬化症患者的疾病表现与生存
本研究从452例系统性硬化症(SSc)前瞻性队列中纳入128例至少有一次CT检查的患者,用人工智能三维体成分分析算法评估肌肉体积、脂肪组织隔室和骨密度,分析其与临床、实验室、功能参数及生存的关系。基于体成分参数的回归模型预测生存的AUC=0.75,优于基于体重指数和临床参数的模型;心脏标志物的纵向变化预测生存AUC=0.82。体成分参数改变的患者多种并发症的OR升高,包括间质性肺病(p<0.05);识别出两种体成分表型,其胃肠道疾病表现差异有统计学意义(p<0.01)。
要点
- 基于体成分参数的回归模型预测生存AUC=0.75,优于体重指数和临床参数模型。
- 心脏标志物纵向变化预测生存AUC=0.82。
- 体成分参数改变的患者间质性肺病等并发症OR升高(p<0.05);两种体成分表型胃肠道疾病表现差异有统计学意义(p<0.01)。
原文
INTRODUCTION: Systemic sclerosis (SSc) is a complex inflammatory vasculopathy with diverse symptoms and variable disease progression. Despite its known impact on body composition (BC), clinical decision-making has yet to incorporate these biomarkers. This study aims to extract quantitative BC imaging biomarkers from CT scans to assess disease severity, define BC phenotypes, track changes over time and predict survival. MATERIALS AND METHODS: CT exams were extracted from a prospectively maintained cohort of 452 SSc patients. 128 patients with at least one CT exam were included. An artificial intelligence-based 3D body composition analysis (BCA) algorithm assessed muscle volume, different adipose tissue compartments, and bone mineral density. These parameters were analysed with regard to various clinical, laboratory, functional parameters and survival. Phenotypes were identified performing K-means cluster analysis. Longitudinal evaluation of BCA changes employed regression analyses. RESULTS: A regression model using BCA parameters outperformed models based on Body Mass Index and clinical parameters in predicting survival (area under the curve (AUC)=0.75). Longitudinal development of the cardiac marker enabled prediction of survival with an AUC=0.82. Patients with altered BCA parameters had increased ORs for various complications, including interstitial lung disease (p<0.05). Two distinct BCA phenotypes were identified, showing significant differences in gastrointestinal disease manifestations (p<0.01). CONCLUSION: This study highlights several parameters with the potential to reshape clinical pathways for SSc patients. Quantitative BCA biomarkers offer a means to predict survival and individual disease manifestations, in part outperforming established parameters. These insights open new avenues for research into the mechanisms driving body composition changes in SSc and for developing enhanced disease management tools, ultimately leading to more personalised and effective patient care.
引用
- Sieren MM, Grasshoff H, Riemekasten G, et al. Computed tomography-derived quantitative imaging biomarkers enable the prediction of disease manifestations and survival in patients with systemic sclerosis. RMD Open. 2025. PMID: 40562681. doi:10.1136/rmdopen-2024-005090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。